Thierry Bonnaud
Principal Scientist - Solid Form and Particle Engineering at Veranova
Thierry Bonnaud has a background in organic synthesis and drug discovery and over 27 years of experience in the industry. He worked at the Neuroscience Centre of Pfizer in 1999 in Cambridge (UK) then in 2000 joined the combinatorial chemistry group of Medivir (Cambridge, UK) where he was involved in the synthesis of new enzyme inhibitors.
He joined Pharmorphix® part of SAFC Pharma (Cambridge, UK) in 2007 and has continued to work at the site which today serves as the global centre of excellence for Solid Form and Particle Engineering at Veranova, a global CDMO. During this time, he has had several roles of increasing seniority spanning project and technical leadership. His technical interests and acumen span salt, polymorphism and cocrystal studies including chiral separation. He is the co-author of a review on cocrystals and co-authors of over 20 patent applications.